The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.
Ribonucleotide reductase and cancer: biological mechanisms and targeted therapies
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Duxbury, M. S., Ito, H., Zinner, M. J., Ashley, S. W., & Whang, E. E. (2004) · Oncogene · doi:10.1038/sj.onc.1207272 · Cited by 224
RetractedDuxbury, M. S., Ito, H., Benoit, E., Zinner, M. J., Ashley, S. W., & Whang, E. E. (2004) · Surgery · doi:10.1016/j.surg.2004.04.029 · Cited by 52
RetractedMetabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233
The DNA damage response: putting checkpoints in perspective
Zhou, B.-B. S., & Elledge, S. J. (2000) · Nature · doi:10.1038/35044005 · Cited by 3,213
Protein Radicals in Enzyme Catalysis
Stubbe, J., & van der Donk, W. A. (1998) · Chemical Reviews · doi:10.1021/cr9400875 · Cited by 1,377
Nordlund, P., & Reichard, P. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142443 · Cited by 1,079
A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage
Tanaka, H., Arakawa, H., Yamaguchi, T., Shiraishi, K., Fukuda, S., Matsui, K., Takei, Y., & Nakamura, Y. (2000) · Nature · doi:10.1038/35003506 · Cited by 904
Gene expression profiles of human breast cancer progression
Ma, X.-J., Salunga, R., Tuggle, J. T., Gaudet, J., Enright, E., McQuary, P., Payette, T., Pistone, M., Stecker, K., Zhang, B. M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931261100 · Cited by 887
Replication stress links structural and numerical cancer chromosomal instability
Burrell, R. A., McClelland, S. E., Endesfelder, D., Groth, P., Weller, M.-C., Shaikh, N., Domingo, E., Kanu, N., Dewhurst, S. M., Gronroos, E., et al. (2013) · Nature · doi:10.1038/nature11935 · Cited by 878
Nucleotide deficiency promotes genomic instability in early stages of cancer development
Bester, A. C., Roniger, M., Oren, Y. S., Im, M. M., Sarni, D., Chaoat, M., Bensimon, A., Zamir, G., Shewach, D. S., & Kerem, B. (2011) · Cell · doi:10.1016/j.cell.2011.03.044 · Cited by 858
INTERACTIONS BETWEEN DEOXYRIBONUCLEOTIDE AND DNA SYNTHESIS
Reichard, P. (1988) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.57.070188.002025 · Cited by 779
siRNA delivery systems for cancer treatment
Oh, Y.-K., & Park, T. G. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.04.018 · Cited by 645
Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy
Saada, A., Shaag, A., Mandel, H., Nevo, Y., Eriksson, S., & Elpeleg, O. (2001) · Nature Genetics · doi:10.1038/ng751 · Cited by 628
Dormant origins licensed by excess Mcm2–7 are required for human cells to survive replicative stress
Ge, X. Q., Jackson, D. A., & Blow, J. J. (2007) · Genes & Development · doi:10.1101/gad.457807 · Cited by 604
Mandel, H., Szargel, R., Labay, V., Elpeleg, O., Saada, A., Shalata, A., Anbinder, Y., Berkowitz, D., Hartman, C., Barak, M., et al. (2001) · Nature Genetics · doi:10.1038/ng746 · Cited by 588
Structure of ribonucleotide reductase protein R1
Uhlin, U., & Eklund, H. (1994) · Nature · doi:10.1038/370533a0 · Cited by 573
Bourdon, A., Minai, L., Serre, V., Jais, J.-P., Sarzi, E., Aubert, S., Chrétien, D., de Lonlay, P., Paquis-Flucklinger, V., Arakawa, H., et al. (2007) · Nature Genetics · doi:10.1038/ng2040 · Cited by 531
Thioredoxins and Glutaredoxins: Unifying Elements in Redox Biology
Meyer, Y., Buchanan, B. B., Vignols, F., & Reichheld, J.-P. (2009) · Annual Review of Genetics · doi:10.1146/annurev-genet-102108-134201 · Cited by 488
Reactive oxygen species in tumorigenesis.
Feig, D. I., Reid, T. M., & Loeb, L. A. (1994) · PubMed · Cited by 468
DNA Synthesis and Repair Genes RRM1 and ERCC1 in Lung Cancer
Zheng, Z., Chen, T., Li, X., Haura, E., Sharma, A., & Bepler, G. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065411 · Cited by 462
Burrell, R. A., McClelland, S. E., Endesfelder, D., Groth, P., Weller, M.-C., Shaikh, N., Domingo, E., Kanu, N., Dewhurst, S. M., Gronroos, E., et al. (2013) · Nature · doi:10.1038/nature12369 · Cited by 451
Chabes, A., Georgieva, B., Domkin, V., Zhao, X., Rothstein, R., & Thelander, L. (2003) · Cell · doi:10.1016/s0092-8674(03)00075-8 · Cited by 436
Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency.
Cohen, A., Hirschhorn, R., Horowitz, S. D., Rubinstein, A., Polmar, S. H., Hong, R., & Martin, D. W. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.1.472 · Cited by 399
D'Angiolella, V., Donato, V., Forrester, F. M., Jeong, Y.-T., Pellacani, C., Kudo, Y., Saraf, A., Florens, L., Washburn, M. P., & Pagano, M. (2012) · Cell · doi:10.1016/j.cell.2012.03.043 · Cited by 395
Sterkers, Y., Preudhomme, C., Laı̈, J.-L., Demory, J.-L., Caulier, M.-T., Wattel, E., Bordessoule, D., Bauters, F., & Fenaux, P. (1998) · Blood · doi:10.1182/blood.v91.2.616 · Cited by 372
Finch, R. A., Liu, M.-C., Grill, S. P., Rose, W. C., Loomis, R., Vasquez, K. M., Cheng, Y.-C., & Sartorelli, A. C. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00419-0 · Cited by 366
Martin, K. R., & Barrett, J. C. (2002) · Human & Experimental Toxicology · doi:10.1191/0960327102ht213oa · Cited by 363
Dynamics of DNA Replication in Mammalian Somatic Cells
Anglana, M., Apiou, F., Bensimon, A., & Debatisse, M. (2003) · Cell · doi:10.1016/s0092-8674(03)00569-5 · Cited by 341
Bepler, G., Kusmartseva, I., Sharma, S., Gautam, A., Cantor, A., Sharma, A., & Simon, G. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.1101 · Cited by 333
Long-Term Follow-Up of Patients With Hairy Cell Leukemia After Cladribine Treatment
Saven, A., Burian, C., Koziol, J. A., & Piro, L. D. (1998) · Blood · doi:10.1182/blood.v92.6.1918 · Cited by 329
Ceppi, P., Volante, M., Novello, S., Rapa, I., Danenberg, K. D., Danenberg, P. V., Cambieri, A., Selvaggi, G., Saviozzi, S., Calogero, R., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl300 · Cited by 323
Comparison between DNA melting thermodynamics and DNA polymerase fidelity.
Petruska, J., Goodman, M. F., Boosalis, M. S., Sowers, L. C., Cheong, C., & Tinoco, I. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.17.6252 · Cited by 316
Ribonucleotide Reductase and Cell Proliferation
Elford, H. L., Freese, M., Passamani, E., & Morris, H. P. (1970) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)62745-0 · Cited by 312
DNA precursor metabolism and genomic stability
Mathews, C. K. (2006) · The FASEB Journal · doi:10.1096/fj.06-5730rev · Cited by 311
Base mispair extension kinetics. Comparison of DNA polymerase alpha and reverse transcriptase.
Mendelman, L. V., Petruska, J., & Goodman, M. F. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39981-8 · Cited by 290
Håkansson, P., Hofer, A., & Thelander, L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512894200 · Cited by 289
Aird, K. M., Zhang, G., Li, H., Tu, Z., Bitler, B. G., Garipov, A., Wu, H., Wei, Z., Wagner, S. N., Herlyn, M., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.03.004 · Cited by 285
Engström, Y., Eriksson, S., Jildevik, I., Skog, S., Thelander, L., & Tribukait, B. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39337-7 · Cited by 285
Ribonucleotide Reductase Inhibitors and Future Drug Design
Shao, J., Zhou, B., Chu, B., & Yen, Y. (2006) · Current Cancer Drug Targets · doi:10.2174/156800906777723949 · Cited by 284
Tang, H., Xiao, G., Behrens, C., Schiller, J., Allen, J., Chow, C.-W., Suraokar, M., Corvalan, A., Mao, J., White, M. A., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2321 · Cited by 284
Davidson, J. D., Ma, L., Flagella, M., Geeganage, S., Gelbert, L. M., & Slapak, C. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3363 · Cited by 280
Reversible, Long-Range Radical Transfer in E. coli Class Ia Ribonucleotide Reductase
Minnihan, E. C., Nocera, D. G., & Stubbe, J. (2013) · Accounts of Chemical Research · doi:10.1021/ar4000407 · Cited by 269
DNA building blocks: keeping control of manufacture
Hofer, A., Crona, M., Logan, D. T., & Sjöberg, B.-M. (2012) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2011.630372 · Cited by 260
Discovery and development of clofarabine: a nucleoside analogue for treating cancer
Bonate, P. L., Arthaud, L., Cantrell, W. R., Stephenson, K., Secrist, J. A., & Weitman, S. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2055 · Cited by 257
Drug delivery of siRNA therapeutics: potentials and limits of nanosystems
Reischl, D., & Zimmer, A. (2009) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2008.06.001 · Cited by 253
Eriksson, S., Gräslund, A., Skog, S., Thelander, L., & Tribukait, B. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)71265-2 · Cited by 245
DNA damage and cell cycle regulation of ribonucleotide reductase
Elledge, S. J., Zhou, Z., Allen, J. B., & Navas, T. A. (1993) · BioEssays · doi:10.1002/bies.950150507 · Cited by 242
Replication fork movement sets chromatin loop size and origin choice in mammalian cells
Courbet, S., Gay, S., Arnoult, N., Wronka, G., Anglana, M., Brison, O., & Debatisse, M. (2008) · Nature · doi:10.1038/nature07233 · Cited by 237
A ribonucleotide reductase gene is a transcriptional target of p53 and p73
Nakano, K., Bálint, É., Ashcroft, M., & Vousden, K. H. (2000) · Oncogene · doi:10.1038/sj.onc.1203774 · Cited by 233
Hehlmann, R., Heimpel, H., Hasford, J., Kolb, H., Pralle, H., Hossfeld, D., Queisser, W., Loffler, H., Heinze, B., & Georgii, A. (1993) · Blood · doi:10.1182/blood.v82.2.398.398 · Cited by 223
Weinberg, G., Ullman, B., & Martin, D. W. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.4.2447 · Cited by 222
Class I Ribonucleotide Reductases: Metallocofactor Assembly and Repair In Vitro and In Vivo
Cotruvo, J. A., & Stubbe, J. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061408-095817 · Cited by 212
Nakahira, S., Nakamori, S., Tsujie, M., Takahashi, Y., Okami, J., Yoshioka, S., Yamasaki, M., Marubashi, S., Takemasa, I., Miyamoto, A., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22390 · Cited by 209
Ribonucleotide reductases: radical enzymes with suicidal tendencies
Stubbe, J., & van der Donk, W. A. (1995) · Chemistry & Biology · doi:10.1016/1074-5521(95)90084-5 · Cited by 200
Guittet, O., Håkansson, P., Voevodskaya, N., Fridd, S., Gräslund, A., Arakawa, H., Nakamura, Y., & Thelander, L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106088200 · Cited by 197
Chaston, T. B., Lovejoy, D. B., Watts, R., & Richardson, D. R. (2003) · PubMed · Cited by 192
Bergman, A. M., Eijk, P. P., Ruiz van Haperen, V. W. T., Smid, K., Veerman, G., Hubeek, I., van den IJssel, P., Ylstra, B., & Peters, G. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0989 · Cited by 182
Bepler, G., Sharma, S., Cantor, A., Gautam, A., Haura, E., Simon, G., Sharma, A., Sommers, E., & Robinson, L. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.12.002 · Cited by 179
Simon, G., Sharma, A., Li, X., Hazelton, T., Walsh, F., Williams, C., Chiappori, A., Haura, E., Tanvetyanon, T., Antonia, S., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.2099 · Cited by 179
Chabes, A., & Thelander, L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000799200 · Cited by 178
Reynolds, C., Obasaju, C., Schell, M. J., Li, X., Zheng, Z., Boulware, D., Caton, J. R., DeMarco, L. C., O'Rourke, M. A., Shaw Wright, G., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.21.9766 · Cited by 172
Fairman, J. W., Wijerathna, S. R., Ahmad, M. F., Xu, H., Nakano, R., Jha, S., Prendergast, J., Welin, R. M., Flodin, S., Roos, A., et al. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2007 · Cited by 168
Chabes, A. L., Pfleger, C. M., Kirschner, M. W., & Thelander, L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0330774100 · Cited by 167
Zhang, Y., Jones, T. L., Martin, S. E., Caplen, N. J., & Pommier, Y. G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.003020 · Cited by 165
The ribonucleotide reductase large subunit (RRM1) as a predictive factor in patients with cancer
Jordheim, L. P., Sève, P., Trédan, O., & Dumontet, C. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70244-8 · Cited by 164
Fersht, A. R. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.10.4946 · Cited by 163
Nutting, C. M., van Herpen, C. M. L., Miah, A. B., Bhide, S. A., Machiels, J.-P., Buter, J., Kelly, C., Raucourt, D. D., & Harrington, K. J. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn775 · Cited by 147
RRM1-induced metastasis suppression through PTEN-regulated pathways
Gautam, A., Li, Z.-R., & Bepler, G. (2003) · Oncogene · doi:10.1038/sj.onc.1206232 · Cited by 146
The effects of dNTP pool imbalances on frameshift fidelity during DNA replication.
Bębenek, K., Roberts, J. D., & Kunkel, T. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50565-8 · Cited by 144
Nyholm, S. H., Thelander, L., & Gräslund, A. (1993) · Biochemistry · doi:10.1021/bi00094a013 · Cited by 142
Formation of Deoxycytidine Phosphates from Cytidine Phosphates in Extracts from Escherichia coli
Reichard, P. A., Baldesten, A., & Rutberg, L. (1961) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64258-9 · Cited by 142
Kimura, T., Takeda, S., Sagiya, Y., Gotoh, M., Nakamura, Y., & Arakawa, H. (2003) · Nature Genetics · doi:10.1038/ng1212 · Cited by 141
A molecular view on signal transduction by the apoptosome
Reubold, T. F., & Eschenburg, S. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.03.007 · Cited by 140
p53R2-dependent pathway for DNA synthesis in a p53-regulated cell cycle checkpoint.
Yamaguchi, T., Matsuda, K., Sagiya, Y., Iwadate, M., Fujino, M. A., Nakamura, Y., & Arakawa, H. (2001) · PubMed · Cited by 136
Niida, H., Katsuno, Y., Sengoku, M., Shimada, M., Yukawa, M., Ikura, M., Ikura, T., Kohno, K., Shima, H., Suzuki, H., et al. (2010) · Genes & Development · doi:10.1101/gad.1863810 · Cited by 136
Pontarin, G., Ferraro, P., Bee, L., Reichard, P. A., & Bianchi, V. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211289109 · Cited by 134
Popović-Bijelić, A. D., Kowol, C. R., Lind, M. E. S., Luo, J., Himo, F., Enyedy, É. A., Arion, V. B., & Gräslund, A. (2011) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2011.07.003 · Cited by 130
Significance of RRM1 and ERCC1 expression in resectable pancreatic adenocarcinoma
Akita, H., Zheng, Z., Takeda, Y., Kim, C. Y., Kittaka, N., Kobayashi, S., Marubashi, S., Takemasa, I., Nagano, H., Dono, K., et al. (2009) · Oncogene · doi:10.1038/onc.2009.158 · Cited by 129
Chandra, D., Bratton, S. B., Person, M. D., Tian, Y., Martín, Á. G., Ayres, M., Fearnhead, H. O., Gandhi, V. V., & Tang, D. G. (2006) · Cell · doi:10.1016/j.cell.2006.05.026 · Cited by 127
Perrino, F. W., & Loeb, L. A. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)81697-6 · Cited by 126
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia
Ferracin, M., Zagatti, B., Rizzotto, L., Cavazzini, F., Veronese, A., Ciccone, M., Saccenti, E., Lupini, L., Grilli, A., Angeli, C. D., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-123 · Cited by 125
Anderson, D. D., Woeller, C. F., Chiang, E. I., Shane, B., & Stover, P. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.333120 · Cited by 124
Regulation by degradation, a cellular defense against deoxyribonucleotide pool imbalances
Rampazzo, C., Miazzi, C., Franzolin, E., Pontarin, G., Ferraro, P., Frangini, M., Reichard, P. A., & Bianchi, V. (2010) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2010.06.002 · Cited by 124
Mitochondrial Neurogastrointestinal Encephalopathy Due to Mutations in RRM2B
Shaibani, A. I., Shchelochkov, O. A., Zhang, S., Katsonis, P., Lichtarge, O., Wong, L.-J. C., & Shinawi, M. S. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.139 · Cited by 123
Tyynismaa, H., Ylikallio, E., Patel, M. D., Molnár, M. J., Haller, R. G., & Suomalainen, A. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.07.009 · Cited by 123
Gon, S., Napolitano, R. L., Rocha, W., Coulon, S., & Fuchs, R. P. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113664108 · Cited by 121
MODULATION OF MUTAGENESIS BY DEOXYRIBONUCLEOTIDE LEVELS
Kunz, B. A., & Kohalmi, S. E. (1991) · Annual Review of Genetics · doi:10.1146/annurev.ge.25.120191.002011 · Cited by 116
Enhanced subunit interactions with gemcitabine-5′-diphosphate inhibit ribonucleotide reductases
Wang, J., Lohman, G. J. S., & Stubbe, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706803104 · Cited by 112
Ribonucleotide reduction is a cytosolic process in mammalian cells independently of DNA damage
Pontarin, G., Fijolek, A., Pizzo, P., Ferraro, P., Rampazzo, C., Pozzan, T., Thelander, L., Reichard, P. A., & Bianchi, V. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808198105 · Cited by 112
Inhibitors of ribonucleotide reductase
Cory, J. G., Cory, A. H., Rappa, G., Lorico, A., Liu, M., Lin, T., & Sartorelli, A. C. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90105-8 · Cited by 109
Chabes, A. L., Björklund, S., & Thelander, L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312482200 · Cited by 109
Localization of ribonucleotide reductase in mammalian cells.
Engström, Y., Rozell, B., Hansson, H., Stemme, S., & Thelander, L. (1984) · The EMBO Journal · doi:10.1002/j.1460-2075.1984.tb01897.x · Cited by 109
Ribonucleotide reductase inhibitors: new strategies for cancer chemotherapy
Nocentini, G. (1996) · Critical Reviews in Oncology/Hematology · doi:10.1016/1040-8428(95)00187-5 · Cited by 108
Enzymatically Active Mammalian Ribonucleotide Reductase Exists Primarily as an α6β2 Octamer
Rofougaran, R., Vodnala, M., & Hofer, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605573200 · Cited by 105
Nucleic Acids as Therapeutic Agents
Álvarez-Salas, L. M. (2008) · Current Topics in Medicinal Chemistry · doi:10.2174/156802608786141133 · Cited by 105
Morikawa, T., Maeda, D., Kume, H., Homma, Y., & Fukayama, M. (2010) · Histopathology · doi:10.1111/j.1365-2559.2010.03725.x · Cited by 103
Evidence for lesion bypass by yeast replicative DNA polymerases during DNA damage
Sabouri, N., Viberg, J., Goyal, D., Johansson, E., & Chabes, A. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn555 · Cited by 102
Zhang, K., Hu, S., Wu, J., Chen, L., Lu, J., Wang, X., Liu, X., Zhou, B., & Yen, Y. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-11 · Cited by 101
Fan, H., Huang, A., Villegas, C., & Wright, J. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13181 · Cited by 100
Bepler, G., Sommers, K. E., Cantor, A. B., Li, X., Sharma, A., Williams, C. C., Chiappori, A., Haura, E. B., Antonia, S. J., Tanvetyanon, T., et al. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181874936 · Cited by 100
Pontarin, G., Ferraro, P., Håkansson, P., Thelander, L., Reichard, P. A., & Bianchi, V. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701310200 · Cited by 98
Liu, X., Zhang, H., Lai, L. L., Wang, X., Loera, S., Xue, L., Hui-yin, H., Zhang, K., Hu, S., Huang, Y., et al. (2012) · Clinical Science · doi:10.1042/cs20120240 · Cited by 97
Broad Overexpression of Ribonucleotide Reductase Genes in Mice Specifically Induces Lung Neoplasms
Xu, X., Page, J. L., Surtees, J. A., Liu, H., Lagedrost, S. J., Lu, Y., Bronson, R. T., Alani, E., Nikitin, A. Y., & Weiss, R. S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5873 · Cited by 93
Self-citationWheeler, L. J., Rajagopal, I., & Mathews, C. K. (2005) · DNA repair · doi:10.1016/j.dnarep.2005.09.003 · Cited by 93
Lee, Y., Vassilakos, A., Feng, N., Lam, V., Xie, H., Wang, M., Jin, H., Xiong, K., Liu, C., Wright, J., et al. (2003) · PubMed · Cited by 91
Systemic delivery of siRNA nanoparticles targeting RRM2 suppresses head and neck tumor growth
Rahman, M. A., Amin, A. R. M. R., Wang, X., Zuckerman, J. E., Choi, C. H. J., Zhou, B., Wang, D., Nannapaneni, S., Koenig, L., Chen, Z., et al. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.045 · Cited by 88
Kashlan, O. B., & Cooperman, B. S. (2003) · Biochemistry · doi:10.1021/bi020634d · Cited by 87
Fan, H., Villegas, C., Huang, A., & Wright, J. (1998) · PubMed · Cited by 86
Månsson, E., Thelander, E. F., Liliemark, J. O., Spasokoukotskaja, T., Elford, H. L., Bajalica‐Lagercrantz, S., Eriksson, S., & Albertioni, F. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01484-3 · Cited by 85
Mannava, S., Moparthy, K., Wheeler, L. J., Natarajan, V., Zucker, S. N., Fink, E. E., Im, M. M., Flanagan, S. A., Burhans, W. C., Zeitouni, N. C., et al. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.09.011 · Cited by 85
Engström, Y., & Rozell, B. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02987.x · Cited by 83
Lin, Z. P., Belcourt, M. F., Cory, J. G., & Sartorelli, A. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402056200 · Cited by 83
Suppression of Lung Tumor Formation by the Regulatory Subunit of Ribonucleotide Reductase
Gautam, A., & Bepler, G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4462 · Cited by 80
Gong, W., Zhang, X., Wu, J., Chen, L., Li, L., Sun, J., Lv, Y., Wei, X., Du, Y., Jin, H., et al. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.08.003 · Cited by 79
Aye, Y., Long, M. J. C., & Stubbe, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.396911 · Cited by 76
Self-citationHurta, R. A. R., & Wright, J. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50537-3 · Cited by 72
A novel homozygous RRM2B missense mutation in association with severe mtDNA depletion
Kollberg, G., Darín, N., Benan, K., Moslemi, A., Lindal, S., Tulinius, M., Oldfors, A., & Holme, E. (2009) · Neuromuscular Disorders · doi:10.1016/j.nmd.2008.11.014 · Cited by 72
Aye, Y., & Stubbe, J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013274108 · Cited by 70
Self-citationTumor Cells Require Thymidylate Kinase to Prevent dUTP Incorporation during DNA Repair
Hu, C.-M., Yeh, M.-T., Tsao, N., Chen, C., Gao, Q.-Z., Chang, C.-Y., Lee, M.-H., Fang, J., Sheu, S., Lin, C.-J., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.04.038 · Cited by 69
Moss, J., Tinline-Purvis, H., Walker, C. A., Folkes, L. K., Stratford, M. R. L., Hayles, J., Hoe, K., Kim, D.-U., Park, H.-O., Kearsey, S. E., et al. (2010) · Genes & Development · doi:10.1101/gad.1970810 · Cited by 66
Jordheim, L. P., Guittet, O., Lepoivre, M., et al. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0121 · Cited by 66
Ribonucleotide Reductase Small Subunit M2B Prognoses Better Survival in Colorectal Cancer
Liu, X., Lai, L. L., Wang, X., Xue, L., Leora, S., Wu, J., Hu, S., Zhang, K., Kuo, M.-L., Zhou, L., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0054 · Cited by 64
Chang, L., Zhou, B., Hu, S., Guo, R., Liu, X., Jones, S. N., & Yen, Y. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803313105 · Cited by 64
Aird, K. M., Li, H., Xin, F., Konstantinopoulos, P. A., & Zhang, R. (2013) · Cell Cycle · doi:10.4161/cc.26953 · Cited by 59
Ferrandina, G., Mey, V., Nannizzi, S., Ricciardi, S., Petrillo, M., Ferlini, C., Danesi, R., Scambia, G., & Tacca, M. D. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1073-y · Cited by 56
Liu, X., Zhou, B., Xue, L., Shih, J., Tye, K. E., Lin, W., Qi, C., Chu, P. G., Un, F., Wen, W. X., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0799 · Cited by 52
Aye, Y., Brignole, E. J., Long, M. J. C., Chittuluru, J. R., Drennan, C. L., Asturias, F. J., & Stubbe, J. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.05.015 · Cited by 51
Self-citationExpression of p53R2 Is Related to Prognosis in Patients with Esophageal Squamous Cell Carcinoma
Okumura, H., Natsugoe, S., Yokomakura, N., Kita, Y., Matsumoto, M., Uchikado, Y., Setoyama, T., Owaki, T., Ishigami, S., & Aikou, T. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2416 · Cited by 51
Fisher, S. B., Patel, S. H., Bağcı, P., Kooby, D. A., El‐Rayes, B. F., Staley, C. A., Adsay, V. N., & Maithel, S. K. (2012) · Cancer · doi:10.1002/cncr.27619 · Cited by 48
Fludarabine phosphate for the first-line treatment of chronic lymphocytic leukaemia
Walker, S., Palmer, S., Erhorn, S., Brent, S., Dyker, A. G., Ferrie, L., Horsley, W. H., Macfarlane, K. W., White, S., & Thomas, S. (2009) · Health Technology Assessment · doi:10.3310/hta13suppl1/06 · Cited by 47
Filatov, D. E., Björklund, S., Johansson, E., & Thelander, L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.39.23698 · Cited by 46
Johansson, E., Hjortsberg, K., & Thelander, L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29816 · Cited by 45
Hypermutability and error catastrophe due to defects in ribonucleotide reductase
Ahluwalia, D., & Schaaper, R. M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310849110 · Cited by 45
Xue, L., Zhou, B., Liu, X., Heung, Y. J., Chau, J., Chu, E., Li, S., Jiang, C., Un, F., & Yen, Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3200 · Cited by 44
Yanamoto, S., Iwamoto, T., Kawasaki, G., Yoshitomi, I., Baba, N., & Mizuno, A. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.10.019 · Cited by 43
Okumura, H., Natsugoe, S., Matsumoto, M., Mataki, Y., 高取, 寛., Ishigami, S., Takao, S., & Aikou, T. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602322 · Cited by 41
Zhu, L., Zhou, B., Chen, X., Jiang, H., Shao, J., & Yen, Y. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.06.103 · Cited by 40
Yanamoto, S., Kawasaki, G., Yoshitomi, I., & Mizuno, A. (2003) · Cancer Letters · doi:10.1016/s0304-3835(02)00588-8 · Cited by 38
Identification of pathways controlling DNA damage induced mutation in Saccharomyces cerevisiae
Lis, E. T., O’Neill, B. M., Gil‐Lamaignere, C., Chin, J. K., & Romesberg, F. E. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.02.007 · Cited by 37
Uramoto, H., Sugio, K., Oyama, T., Hanagiri, T., & Yasumoto, K. (2006) · PubMed · Cited by 34
Activity of ribonucleotide reductase helps determine how cells repair DNA double strand breaks
Burkhalter, M. D., Roberts, S. A., Havener, J. M., & Ramsden, D. A. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.07.009 · Cited by 32
Miyazaki, K. (1994) · Oncology Reports · doi:10.3892/or_00000004 · Cited by 31
Fisher, S. B., & Maithel, S. K. (2013) · Cancer · doi:10.1002/cncr.28115 · Cited by 30
Mannava, S., Moparthy, K., Wheeler, L. J., Leonova, K. I., Wawrzyniak, J. A., Bianchi, A., Berman, A. E., Flanagan, S. A., Shewach, D. S., Zeitouni, N. C., et al. (2012) · Aging · doi:10.18632/aging.100512 · Cited by 29
Dong, X., Hao, Y., Wei, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092320 · Cited by 25
Matsushita, S., Ikeda, R., Fukushige, T., Tajitsu, Y., Gunshin, K., Okumura, H., Ushiyama, M., Akiyama, S., Kawai, K., Takeda, Y., et al. (2012) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2012.07.005 · Cited by 18
Yokomakura, N., Natsugoe, S., Okumura, H., Ikeda, R., Uchikado, Y., Mataki, Y., 高取, 寛., Matsumoto, M., Owaki, T., Ishigami, S., et al. (2007) · Oncology Reports · doi:10.3892/or.18.3.561 · Cited by 18
Upregulation of the p53R2 ribonucleotide reductase subunit by nitric oxide
Guittet, O., Tebbi, A., Cottet, M.-H., Françoise, V., & Lepoivre, M. (2008) · Nitric Oxide · doi:10.1016/j.niox.2008.04.011 · Cited by 15
Avolio-Hunter, T. M., Lee, Y., Feng, N., Xiong, K., Jin, H., Wang, M., Vassilakos, A., Wright, J., & Young, A. H. (2007) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328013c04f · Cited by 14
Jørgensen, C. L. T., Ejlertsen, B., Bjerre, K., Balslev, E., Nielsen, D. L., & Nielsen, K. V. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-541 · Cited by 14
Yanamoto, S., Kawasaki, G., Yamada, S., Yoshitomi, I., Yoshida, H., & Mizuno, A. (2008) · Oral Oncology · doi:10.1016/j.oraloncology.2008.07.005 · Cited by 14
Ribonucleotide Reductase Association with Mammalian Liver Mitochondria
Chimploy, K., Song, S., Wheeler, L. J., & Mathews, C. K. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.461111 · Cited by 13
Fu, Y., Long, M. J. C., Rigney, M., Parvez, S., Blessing, W. A., & Aye, Y. (2013) · Biochemistry · doi:10.1021/bi400781z · Cited by 12
Self-citation
Cited by
siRNA: Mechanism of action, challenges, and therapeutic approaches
Alshaer, W., Zureigat, H., Al Karaki, A., Al-Kadash, A., Gharaibeh, L., Hatmal, M. M., Aljabali, A. A. A., & Awidi, A. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174178 · Cited by 441
Redox Signaling by Reactive Electrophiles and Oxidants
Parvez, S., Long, M. J. C., Poganik, J. R., & Aye, Y. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00698 · Cited by 359
Self-citationNear-infrared photoactivated nanomedicines for photothermal synergistic cancer therapy
Sun, H., Zhang, Q., Li, J., Peng, S., Wang, X., & Cai, R. (2021) · Nano Today · doi:10.1016/j.nantod.2020.101073 · Cited by 332
Gallium and its competing roles with iron in biological systems
Chitambar, C. R. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.04.027 · Cited by 274
Integrative proteogenomic characterization of hepatocellular carcinoma across etiologies and stages
Ng, C. K. Y., Dazert, E., Boldanova, T., Coto-Llerena, M., Nuciforo, S., Ercan, C., Suslov, A., Meier, M.-A., Bock, T., Schmidt, A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29960-8 · Cited by 165
Metadata
- Authors
- Aye, Y., Li, M., Long, M. J. C., & Weiss, R. S.
- Venue
- Oncogene
- Published
- 2014-06-09
- Volume
- 34
- Issue
- 16
- Pages
- 2011-2021
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1973109316
- Cited by
- 436
- References
- 153
- FWCI
- 9.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.